MA30708B1 - Composes de 2-amido-4-isoxazolyl thiazole presentant une activite inhibitrice d'une enzyme utilisant l'atp et compositions et utilisation desdits composes. - Google Patents
Composes de 2-amido-4-isoxazolyl thiazole presentant une activite inhibitrice d'une enzyme utilisant l'atp et compositions et utilisation desdits composes.Info
- Publication number
- MA30708B1 MA30708B1 MA31702A MA31702A MA30708B1 MA 30708 B1 MA30708 B1 MA 30708B1 MA 31702 A MA31702 A MA 31702A MA 31702 A MA31702 A MA 31702A MA 30708 B1 MA30708 B1 MA 30708B1
- Authority
- MA
- Morocco
- Prior art keywords
- atp
- enzyme
- amido
- compositions
- isoxazolyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'INVENTION CONCERNE DES COMPOSÉS DE 2-AMIDO-4-ISOXAZOLYL THIAZOLE PRÉSENTANT UNE ACTIVITÉ INHIBITRICE D'UNE ENZYME UTILISANT L'ATP, DES PROCÉDÉS D'UTILISATION DE COMPOSÉS PRÉSENTANT UNE ACTIVITÉ INHIBITRICE D'UNE ENZYME UTILISANT L'ATP, ET DES COMPOSITIONS COMPRENANT DES COMPOSÉS PRÉSENTANT UNE ACTIVITÉ INHIBITRICE D'UNE ENZYME UTILISANT L'ATP.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83824306P | 2006-08-16 | 2006-08-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA30708B1 true MA30708B1 (fr) | 2009-09-01 |
Family
ID=38982868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA31702A MA30708B1 (fr) | 2006-08-16 | 2009-03-09 | Composes de 2-amido-4-isoxazolyl thiazole presentant une activite inhibitrice d'une enzyme utilisant l'atp et compositions et utilisation desdits composes. |
Country Status (16)
Country | Link |
---|---|
US (1) | US20080242709A1 (fr) |
EP (1) | EP2057157A2 (fr) |
JP (1) | JP2010500998A (fr) |
KR (1) | KR20090038905A (fr) |
CN (1) | CN101522675A (fr) |
AU (1) | AU2007286111A1 (fr) |
BR (1) | BRPI0714535A2 (fr) |
CA (1) | CA2659276A1 (fr) |
CR (1) | CR10616A (fr) |
IL (1) | IL196717A0 (fr) |
MA (1) | MA30708B1 (fr) |
MX (1) | MX2009001625A (fr) |
NO (1) | NO20091107L (fr) |
RU (1) | RU2009109205A (fr) |
WO (1) | WO2008022002A2 (fr) |
ZA (1) | ZA200900605B (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2575466A1 (fr) * | 2004-08-13 | 2006-02-23 | Genentech, Inc. | Composes a base de 2-amido-thiazole presentant une activite inhibitrice enzymatique utilisant de l'adenosine triphosphate (atp), et compositions, et leurs utilisations |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2575466A1 (fr) * | 2004-08-13 | 2006-02-23 | Genentech, Inc. | Composes a base de 2-amido-thiazole presentant une activite inhibitrice enzymatique utilisant de l'adenosine triphosphate (atp), et compositions, et leurs utilisations |
-
2007
- 2007-08-09 AU AU2007286111A patent/AU2007286111A1/en not_active Abandoned
- 2007-08-09 CN CNA2007800367521A patent/CN101522675A/zh active Pending
- 2007-08-09 WO PCT/US2007/075648 patent/WO2008022002A2/fr active Application Filing
- 2007-08-09 RU RU2009109205/04A patent/RU2009109205A/ru not_active Application Discontinuation
- 2007-08-09 MX MX2009001625A patent/MX2009001625A/es unknown
- 2007-08-09 US US11/836,528 patent/US20080242709A1/en not_active Abandoned
- 2007-08-09 JP JP2009524744A patent/JP2010500998A/ja active Pending
- 2007-08-09 CA CA002659276A patent/CA2659276A1/fr not_active Abandoned
- 2007-08-09 KR KR1020097003005A patent/KR20090038905A/ko not_active Application Discontinuation
- 2007-08-09 ZA ZA200900605A patent/ZA200900605B/xx unknown
- 2007-08-09 EP EP07800075A patent/EP2057157A2/fr not_active Withdrawn
- 2007-08-09 BR BRPI0714535-7A patent/BRPI0714535A2/pt not_active Application Discontinuation
-
2009
- 2009-01-26 IL IL196717A patent/IL196717A0/en unknown
- 2009-02-13 CR CR10616A patent/CR10616A/es unknown
- 2009-03-09 MA MA31702A patent/MA30708B1/fr unknown
- 2009-03-13 NO NO20091107A patent/NO20091107L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2010500998A (ja) | 2010-01-14 |
KR20090038905A (ko) | 2009-04-21 |
CA2659276A1 (fr) | 2008-02-21 |
CR10616A (es) | 2009-05-25 |
CN101522675A (zh) | 2009-09-02 |
NO20091107L (no) | 2009-05-15 |
WO2008022002A3 (fr) | 2008-10-09 |
WO2008022002A2 (fr) | 2008-02-21 |
ZA200900605B (en) | 2010-04-28 |
EP2057157A2 (fr) | 2009-05-13 |
AU2007286111A1 (en) | 2008-02-21 |
US20080242709A1 (en) | 2008-10-02 |
MX2009001625A (es) | 2009-02-23 |
BRPI0714535A2 (pt) | 2013-07-02 |
IL196717A0 (en) | 2009-11-18 |
RU2009109205A (ru) | 2010-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200621253A (en) | 2-amido-thiazole-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof | |
MA30531B1 (fr) | Anticorps anti-dll4 et leurs procedes d'utilisation | |
BRPI0606379A2 (pt) | triazolftalazinas | |
NO20082482L (no) | Karbonylamino pyrrolpyrazoler, samt anvendelse som kinase inhibitorer | |
TW200718687A (en) | Inhibitors of cytosolic phospholipase A2 | |
NO20083153L (no) | Kjemiske forbindelser | |
UA93351C2 (uk) | Похідні фталазіну як інгібітори parp | |
MXPA06011046A (es) | Ciertos compuestos basados en triazol, composiciones, y usos de los mismos. | |
MA29141B1 (fr) | Pyrrolopyrazoles, servant de puissants inhibiteurs de kinases | |
EA200702568A1 (ru) | Гетеробициклические ингибиторы металлопротеазы и их применение | |
EA200602062A1 (ru) | Амидосоединения и их применение в качестве фармацевтических средств | |
IL213342A0 (en) | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme | |
BRPI0608886B8 (pt) | derivados de n-sulfonilpirróis e seus usos | |
ATE461923T1 (de) | Substituierte 1h-benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren | |
MA31151B1 (fr) | Inhibiteurs de mapk/erk kinase | |
BR0313330A (pt) | Piperidina-ftalazonas substituìdas com pirrolidinadiona como inibidores de pde4 | |
DK1888584T3 (da) | Tricykliske 1,6-dihydro- 1,3,5,6-tetraaza-as-indacen-baserede forbindelser og farmaceutiske sammensætninger omfattende samme som hæmmere af IKK-enzymaktivitet | |
ATE533759T1 (de) | Imidazolinon- und hydantoinderivate als neue inhibitoren von histondeacetylase | |
ATE464307T1 (de) | Mif-hemmer | |
NO20082298L (no) | Kaliumkanalinhibitorer | |
ATE509920T1 (de) | Quadratsäurederivate als inhibitoren von histondeacetylase | |
EA201000566A1 (ru) | Гетероциклические сетр ингибиторы | |
MA30331B1 (fr) | ANTICORPS à EFGL 7 ET LEURS PROCEDES D'UTILISATION | |
BR0317284A (pt) | Inibidores aminocianopiridina de proteìna quinase-2 ativada com proteìna quinase ativada com mitógeno | |
ZA200705474B (en) | Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |